| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 10/03/2001 | CN1315864A Powdery preparation for mucosal administration containing polymeric medicine |
| 10/03/2001 | CN1315855A Immediate release tablet |
| 10/03/2001 | CN1315853A Bioenhanced formulations comprising eprosartan in oral dosage form |
| 10/03/2001 | CN1315852A Medicinal aerosol formulations |
| 10/02/2001 | US6297350 Using cyclic esters as monomers and a metallic salt as catalyst, reproducible preparation of copolyesters with a random sequence under controlled conditions, metal salt of an aminocarboxylic acid, hydroxycarboxylic acid or a |
| 10/02/2001 | US6297290 Composition containing a nerve fiber reactivity modulating compound |
| 10/02/2001 | US6297277 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 10/02/2001 | US6297266 Inhibit the binding of adhesive proteins to the surface of different types of cell and accordingly influence cell-cell and cell-matrix interactions. |
| 10/02/2001 | US6297244 Stable drug composition |
| 10/02/2001 | US6297219 Site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 10/02/2001 | US6297218 Phospholipid complexes prepared from extracts of Vitis vinifera as anti-atherosclerotic agents |
| 10/02/2001 | US6296877 Stable, aqueous dispersions and stable, water-dispersible dry xanthophyll powder, their production and use |
| 10/02/2001 | US6296875 Method for producing a granule |
| 10/02/2001 | US6296872 Tablet composition of N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine |
| 10/02/2001 | US6296869 Adhesive cosmetic patch containing alpha or beta hydroxy acids |
| 10/02/2001 | US6296850 Apoptosis-related compounds and their use |
| 10/02/2001 | US6296847 Composition for treating benign prostatic hypertrophy |
| 10/02/2001 | US6296844 Administering asialointerferon-.beta.. to mammal for therapy of viral hepatitis |
| 10/02/2001 | US6296831 Biodegradation; in cancer tumor therapy |
| 10/02/2001 | CA2084680C Process for the manufacture of porous cellulose matrices |
| 09/27/2001 | WO2001071359A2 Methods for identifying and isolating tissue-specific lumen-exposed molecules |
| 09/27/2001 | WO2001071005A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 09/27/2001 | WO2001070770A2 Bisubstrate inhibitors of kinases |
| 09/27/2001 | WO2001070694A1 Amorphous torasemide modification |
| 09/27/2001 | WO2001070685A2 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents |
| 09/27/2001 | WO2001070663A2 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| 09/27/2001 | WO2001070577A1 Methods of producing a terminally sterilized topical patch preparation |
| 09/27/2001 | WO2001070291A2 Injectable microspheres for dermal augmentation and tissue bulking |
| 09/27/2001 | WO2001070288A2 Thermoreversible polymers for delivery and retention of osteoinductive proteins |
| 09/27/2001 | WO2001070275A2 Polyglutamic acid-camptothecin conjugates and methods of preparation |
| 09/27/2001 | WO2001070274A2 Local drug delivery |
| 09/27/2001 | WO2001070273A1 The use of anticoagulant agents in the extracorporeal treatment of blood |
| 09/27/2001 | WO2001070272A1 Polysaccharide-polypeptide conjugate |
| 09/27/2001 | WO2001070271A2 Acid-stable base compositions for preparing surfactant free topical compositions |
| 09/27/2001 | WO2001070263A1 Composition and method for the prevention and/or the treatment of allergy |
| 09/27/2001 | WO2001070242A2 Compositions containing molecular iodine |
| 09/27/2001 | WO2001070234A1 Anaesthetic composition |
| 09/27/2001 | WO2001070225A2 Oxazolidinone tablet formulation |
| 09/27/2001 | WO2001070219A1 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 09/27/2001 | WO2001070202A1 Plaster containing an active agent |
| 09/27/2001 | WO2001070200A1 Pharmaceutical composition for administration to mucosal surfaces |
| 09/27/2001 | WO2001070199A1 Matrices containing nitric oxide donors and reducing agents and their use |
| 09/27/2001 | WO2001070198A1 Stabilized dry powder formulations |
| 09/27/2001 | WO2001070194A1 Fast dissolving orally consumable films containing an ion exchange resin as a taste masking agent |
| 09/27/2001 | WO2001070154A1 Device and method for treating urinary incontinence in females |
| 09/27/2001 | WO2001032201A3 A pharmaceutical composition having high cell membrane permeability |
| 09/27/2001 | WO2001030754A3 Micro-cluster liquids and methods of making and using them |
| 09/27/2001 | WO2001021207A3 Use of combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines |
| 09/27/2001 | WO2001020013A3 Viral replicons and viruses dependent on inducing agents |
| 09/27/2001 | WO2001019901A3 Process for making aqueous coated beadlets |
| 09/27/2001 | WO2001019320A3 Phospholipid prodrugs of anti-proliferative drugs |
| 09/27/2001 | WO2001017551A3 Combined vaccine compositions |
| 09/27/2001 | WO2001013895A3 Controlled-release sedative-hypnotic compositions and methods related thereto |
| 09/27/2001 | WO2001003650A3 Preservatives for perishable preparations, in particular for cosmetic and pharmaceutical preparations |
| 09/27/2001 | WO2000078275A3 Antibacterial compositions |
| 09/27/2001 | WO2000041707A3 USE OF $i(LACTOBACILLUS SALIVARIUS) |
| 09/27/2001 | US20010025144 Gas filled liposomes and their use as ultrasonic contrast agents |
| 09/27/2001 | US20010025058 Therapy for fungus infections |
| 09/27/2001 | US20010025046 A stabilized self-emulsifying system, comprising a o-(chloroacetylcarbamoyl)fumigillol drug, a carrier which is an oily constituent, a surfactant and a stabilizer; angiogenesis inhibitor |
| 09/27/2001 | US20010025033 Uracil substituted at 5-position by C2-4 alkynyl used as inactivator of uracil reductase enzyme |
| 09/27/2001 | US20010024829 Forming a complex of polyampholyte and polyion and delivering the complex into a cell; drug delivery |
| 09/27/2001 | US20010024795 Detecting very low concentration of a molecule by contacting a sample with a multispecific molecule capable of binding the molecule to be detected forming a complex, which is then bound by another molecule linked by a polymer to many signals |
| 09/27/2001 | US20010024678 Wrapping film for drugs, cosmetics, foods |
| 09/27/2001 | US20010024663 Sustained release dosage form unit having latex coating and method of making the same |
| 09/27/2001 | US20010024658 A delayed release pharmaceutical dosage form for oral administration of heparin comprising a low molecular weight heparin, a bile salt or acid, and a surfactant selected from hydrophilc and lipophilic, and a means for sustained release |
| 09/27/2001 | US20010024650 Artery - and vein-specific proteins and uses therefor |
| 09/27/2001 | US20010024649 Topical treatment comprises an ester or amide lipophilic molecule capable of traversing the statum corneum and inducing immature dendritic cells to migrat to the draining lymphoid organ |
| 09/27/2001 | US20010024645 Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation |
| 09/27/2001 | US20010024642 A chewing gum that includes a gum center and a coating that substantially surrounds the center, comprises at least 50% by weight of chewing gum, the coating includes medicine; chewing the gum, causes the drug release, in patients buccal cavity |
| 09/27/2001 | US20010024641 Providing particles of at least one active material selected from corticosteroids, beta -agonists, anticholinergics, leukotriene antagonists and inhalable proteins or peptides and a solid binder, agglomerating active particles and binder |
| 09/27/2001 | US20010024636 Thermally reversible stimulus- sensitive gel or gelling copolymer radioisotope carrier that is a linear random copolymer of an (meth)acrylamide derivative and a hydrophil comonomer |
| 09/27/2001 | DE10108727A1 Plaster for transdermal release of active substance(s) has the substance loaded on a molecular sieve which has been partially dehydrated to reduce its water of crytallisation content |
| 09/27/2001 | DE10013712A1 Nikotinsalze mit verbessertem Geschmack, Verfahren zu ihrer Herstellung und ihre Verwendung Nicotine salts with improved taste, process for their preparation and their use |
| 09/27/2001 | DE10012370A1 Use of oil-in-water emulsion as vaccine adjuvant, particularly for influenza and pneumococcal vaccines, administered at different site from the vaccine |
| 09/27/2001 | DE10012151A1 Aerosol inhalant containing vitamin A compound in liposomes based on phosphatidylcholine, useful for treatment of tracheo-bronchial illnesses, especially chronic obstructive pulmonary disease |
| 09/27/2001 | DE10012120A1 New ligand, comprising therapeutic or diagnostic agent bonded non-covalently with substance having high affinity to transport molecule |
| 09/27/2001 | CA2723664A1 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents |
| 09/27/2001 | CA2409333A1 Methods for identifying and isolating tissue-specific lumen-exposed molecules |
| 09/27/2001 | CA2406993A1 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 09/27/2001 | CA2404115A1 The use of peg-hirudin as an anticoagulant agent in the extracorporeal treatment of blood |
| 09/27/2001 | CA2404064A1 Stabilized dry powder formulations |
| 09/27/2001 | CA2403818A1 Matrices containing nitric oxide donors and reducing agents and their use |
| 09/27/2001 | CA2403553A1 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| 09/27/2001 | CA2402643A1 Polyglutamic acid-camptothecin conjugates and methods of preparation |
| 09/27/2001 | CA2402636A1 Composition and method for the prevention and/or the treatment of allergy |
| 09/27/2001 | CA2401908A1 Amorphous torasemide modification |
| 09/27/2001 | CA2400118A1 Oxazolidinone tablet formulation |
| 09/27/2001 | CA2399695A1 Pharmaceutical composition for administration to mucosal surfaces |
| 09/27/2001 | CA2391316A1 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents |
| 09/26/2001 | EP1136487A1 Nicotine salts with improved taste, process for their preparation and use thereof as smoking cessation agents |
| 09/26/2001 | EP1136084A1 Compositions containing thrombin and process for their manufacture |
| 09/26/2001 | EP1136082A1 Local drug delivery |
| 09/26/2001 | EP1136081A1 Sustained-release compositions for the parenteral administration of macrolides |
| 09/26/2001 | EP1136080A2 Use of o-vanillin and o-vanillin/trolox combinations |
| 09/26/2001 | EP1136070A1 Soft capsules comprising polymerisates of vinylesters and polyethers, use and preparation thereof |
| 09/26/2001 | EP1136069A1 Pharmaceutical compositions containing clodronates for high local tolerance intramuscular administration |
| 09/26/2001 | EP1136068A2 Powder containing physiologically active peptide |
| 09/26/2001 | EP1136067A1 Oral formulations of medicaments |
| 09/26/2001 | EP1136065A1 Formulations and methods for reducing skin irritation |
| 09/26/2001 | EP1135995A2 Composition and method for stabilising proanthocyanidin |